Elekta wins lawsuit against Livian GmbH

Elekta announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange.